Updated Jul 16, 2026
Leiderman Elisabeth has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-05-30 | BLUE | bluebird bio, Inc. | D — Derivative transaction | 1.2K | — | |
| 2025-05-30 | BLUE | bluebird bio, Inc. | J — Other acquisition / disposition | 1.1K | — | |
| 2024-11-08 | BLUE | bluebird bio, Inc. | A — Grant or award | 24.9K | $0.00 |
Leiderman Elisabeth is a corporate insider — currently tracked as Director of Autolus Therapeutics plc (AUTL). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Leiderman Elisabeth profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.